Conference Activities & Talks -

Division display >> ／  All the affair displays  1 - 192 of about 192

  1. Tsuji K, Huang X, Kobayakawa T, Burke TR Jr., Tamamura H. Development of high-affinity polo-like kinase 1 polo-box domain binding peptides by bivalent approaches. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  2. Huang X, Tsuji K, KobayakawaT, Tamamura H. Investigation on degrader peptides targeting the polo-box domain for degradation of polo-like kinase 1. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  3. Yamamoto K, Kobayakawa T, Tsuji K, Tamamura H. Development of chloroalkene-type dipeptide isosteres for amyloid-beta aggregation inhibitors. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  4. Shinohara K, Kobayakawa T, Takamatsu Y, Tsuji K, Mitsuya H, Tamamura H. Structure-activity relationship studies of novel SARS-CoV-2 papain-like protease inhibitors and their application as anti-Mpox agents. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  5. Tamamura H. New horizon of drug discovery for anti-HIV drugs. The 82nd FIP World Congress of Pharmacy and Pharmaceutical Sciences, HIV treatment: the future of preventative care and management 2024.09.01 Cape Town, South Africa

  6. Tamamura H. Development of anti-HIV agents targeting HIV-Gag proteins using in silico screening . The 37th European Peptide Symposium (EPS) & 14th International Peptide Symposium (IPS) Satellite Workshops, Applications of computational AI/ML in peptide research with a roadmap to peptide drug and material development 2024.08.30 Florence, Italy

  7. Kobayakawa T, Azuma C, Yamamoto K , Tsuji K, Tamamura H. Convergent synthesis of peptidomimetic based on a chloroalkene dipeptide isostere and its application to inhibition against amyloid β aggregation. 14th International Peptide Symposium 2024.08.26 Florence, Italy

  8. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Tamamura H. Development of antibody drug conjugates as HIV entry inhibitors. 37th European peptide symposium 2024.08.26 Florence, Italy

  9. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Tamamura H. Development of hybrid-molecules as HIV entry inhibitors. 18th Chinese international peptide symposium 2024.07.01 Hong Kong

  10. Tamamura H. Tripeptide-mimic Inhibitors against a Main Protease of SARS-CoV-2. The 18th Chinese International Peptide Symposium 2024.06.30 Hong Kong

  11. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Tamamura H. Antibody drug conjugates as HIV entry inhibitors. 27th Korean Peptide Protein Symposium 2024.06.24 Busan, South Korea

  12. Tamamura H. Medicinal chemistry derived from peptides and peptidomimetics. The 10th Joint Symposium between IBB/TMDU and Chulalongkorn University on Biomedical Materials and Engineering 2024.01.19 Thailand

  13. Takuya Kobayakawa, Chika Azuma, Kenichi Yamamoto, Kohei Tsuji, Hirokazu Tamamura. Development of synthetic strategies for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. The 15th International Kyoto Conference on New Aspects of Organic Chemistry 2023.11.21 Kyoto

  14. Kohei Tsuji, Hirokazu Tamamura, Terrence R. Burke, Jr.. Utilization of a non-specific kinase inhibitor for the development of high-affinity bivalent polo-like kinase 1 polo-box domain inhibitors. The 60th Japanese Peptide Symposium 2023.11.10 Otsu

  15. Takuya Kobayakawa, Chika Azuma, Kenichi Yamamoto, Kohei Tsuji, Hirokazu Tamamura. Development of convergent synthesis for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. The 60th Japanese Peptide Symposium 2023.11.08 Otsu

  16. Kouki Shinohara, Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Yutaro Miura, Chika Azuma, Hironori Hayashi, Shin-ichiro Hattori, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura. Structure-activity relationship studies of novel SARS-CoV-2 main protease inhibitors with potent antiviral activity. The 60th Japanese Peptide Symposium 2023.11.08 Otsu

  17. Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Combinational use of CD4 mimic with other anti-HIV agents and development of these hybrid molecules. 14th International Peptide Symposium 2023.10.17 Brisbane

  18. Hirokazu Tamamura. Anti-SARS-CoV-2 Agents Inspired from HIV Researches. The 13th International Peptide Symposium/The 15th Australian Peptide Conference 2023.10.17 Brisbane

  19. Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Double target inhibitors of HIV-1 entry based on hybrid molecules of CD4 mimics and HIV-1 gp41-related peptides. 26th Korean Peptide Protein Symposium 2023.07.04 Jeju

  20. Takahiro Ishii, Kohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Kouki Shinohara, Yutaro Miura, Hironori Hayashi, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura . Design and Synthesis of SARS-CoV-2 Mpro Inhibitors Containing Flurine Atoms and Amide Surrogates. 26th KPPS Annual Symposium 2023.07.03 Jeju

  21. Hirokazu Tamamura. Anti-SARS-CoV-2 Agents Based on HIV Researches. The Seoul National University (SNU) seminar 2023.06.30 Korea

  22. Takahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, Kohei Tsuji, Nami Ohashi, Kazuhisa Yoshimura, Hiroaki Mitsuya, Kenji Maeda, Hirokazu Tamamura . Structure-Activity Relationship Studies of DAG-lactone Derivatives with HIV-1 Latancy Reversing Activity. 14th AFMC International Medicinal Chemistry Symposium 2023.06.27 Seoul

  23. Hirokazu Tamamura. Development of potent and biostable inhibitors of the main protease of SARS-CoV-2 learned from HIV researches. The 14th AFMC International Medicinal Chemistry Symposium (AIMECS 2023) 2023.06.27 Korea

  24. Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Hybrid molecules of CD4 mimic and HIV-1 fusion inhibitors. 14th AFMC International Medicinal Chemistry Symposium 2023.06.26 Seoul

  25. Hirokazu Tamamura. Peptidomimetic-based Anti-SARS-CoV-2 Agents Learned from Anti-HIV Agents. The 17th Chinese International Peptide Symposium 2023.06.14 China

  26. Hirokazu Tamamura. Development of Anti-SARS-CoV-2 Agents Learned from Anti-HIV Agents. The 19th Akabori Conference 2023: German-Japanese Symposium on Peptide Science 2023.05.19 Otsu

  27. Hirokazu Tamamura. Use of synthetic peptides in infectious diseases research; vaccines, therapeutics and diagnostics. Discovery Research Platforms 2023.03.23 Online

  28. Hirokazu Tamamura. Peptide-lead medicinal chemistry: from AIDS to COVID-19. The 9th Joint Symposium between IBB/TMDU and Chulalongkorn University on Biomedical Materials and Engineering 2023.01.23 Thailand

  29. Kofi Baffour-Awuah Owusu , Kohei Tsuji , Takuya Kobayakawa , Youichi Suzuki, Hirokazu Tamamura. Development of SARS-CoV-2 Fusion Inhibitor Peptides Based on SARS-CoV-2 HR-2. The 39th Medicinal Chemistry Symposium 2022.11.23 Online

  30. Kohei Tsuji, Kofi Baffour-Awuah Owusu, Takuya Kobayakawa, Youichi Suzuki, Hirokazu Tamamura. Development of fusion inhibitor peptides of SARS-CoV-2 learned from anti-HIV-1 agents. The 59th Japanese Peptide Symposium 2022.10.26 Sendai

  31. Takahiro Ishii, Kohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Miyuki Nakayama, Kouki Shinohara, Yutaro Miura, Hironori Hayashi, Shin-ichiro Hattori, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura. Synthesis of inhibitors targeting the main protease of SARS-CoV-2 for therapeutics of COVID-19. The 59th Japanese Peptide Symposium 2022.10.26 Sendai

  32. Yutaro Miura, Takuya Kobayakawa, Kohei Tsuji, Kiju Konno, Ami Masuda, Nami Ohashi, Takeo Kuwata, Kazuhisa Yoshimura, Tomoyuki Miura, Shigeyoshi Harada, Shuzo Matsushita, Hirokazu Tamamura. Pegylated CD4 mimics as HIV inhibitors. The 59th Japanese Peptide Symposium 2022.10.26 Sendai

  33. Kouki Shinohara, Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Yutaro Miura, Hironori Hayashi, Shin-ichiro Hattori, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura. Structure-activity relationship studies of SARS-CoV-2 main protease inhibitors. The 59th Japanese Peptide Symposium 2022.10.26 Sendai

  34. Kohei Tsuji, Rongyi Wang, Kofi Baffour-Awuah Owusu, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. Exploration of novel class anti-HIV-1 agents derived from a viral capsid protein. 36th European and 12th International Peptide Symposium 2022.08.29 Spain

  35. Hirokazu Tamamura . From HIV to SARS-CoV-2: Fusion Inhibitors Based on Dimerization of HR2 Region Peptides. Frontiers in Peptide Science and Drug Discovery: A Scientific Symposium in Honor of Professor James P. Tam 2022.08.05 Singapore

  36. Hirokazu Tamamura. Medicinal chemistry based on peptidomimetics. The 8th Joint Symposium between Chulalongkorn University and IBB/TMDU on Biomedical Materials and Engineering 2022.01.25 Online

  37. Hirokazu Tamamura. Bivalent Ligands of GPCR as Molecular Measures, Bioprobes for Cancer Cells and Anti-cancer Agents. The 2021 International Chemical Congress of Pacific Basin Societies (Pacifichem 2021) 2021.12.20 Online

  38. Hirokazu Tamamura, Takuya Kobayakawa, Kento Ebihara, Tsutomu Murakami, Kohei Tsuji. Development of HIV-1 fusion inhibitors based on dimeric derivatives of the C34 peptide and its peptidomimetics. The 2021 International Chemical Congress of Pacific Basin Societies (Pacifichem 2021) 2021.12.18 Online

  39. Kohei Tsuji, Rongyi Wang, Kofi Baffour-Awuah Owusu, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. Explorative study in development of anti-HIV-1 peptides based on HIV-1 capsid protein segments. The 2021 International Chemical Congress of Pacific Basin Societies (Pacifichem 2021) 2021.12.15 Online

  40. Takahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, Kohei Tsuji, Kazuhisa Yoshimura, Hiroaki Mitsuya, Kenji Maeda, Hirokazu Tamamura. Development of protein kinase C activators for cure of HIV infectious diseases. The 2021 International Chemical Congress of Pacific Basin Societies (Pacifichem 2021) 2021.12.15 Online

  41. Takuya Kobayakawa, Kohei Tsuji, Kiju Konno, Ami Masuda, Nami Ohashi, Takeo Kuwata, Kazuhisa Yoshimura, Tomoyuki Miura, Shigeyoshi Harada, Shuzo Matsushita, Hirokazu Tamamura. HIV entry inhibitors based on CD4 mimics with PEG units toward cure for HIV-infectious diseases. The 13th AFMC International Medicinal Chemistry Symposium 2021.12.02 Online

  42. Takahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, Kohei Tsuji, Kazuhisa Yoshimura, Hiroaki Mitsuya, Kenji Maeda, Hirokazu Tamamura. Structure-Activity Relationship Studies of Protein Kinase C Activators Derived from Diacylglycerol for Cure of HIV Infectious Diseases. The 13th AFMC International Medicinal Chemistry Symposium 2021.11.29 Online

  43. Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. HYBRID MOLECULES OF CD4 MIMIC AND HIV-1 GP41-RELATED PEPTIDES AS FUSION INHIBITORS. The 58th Japanese Peptide Symposium 2021.10.22 Online

  44. Kohei Tsuji, Takuya Kobayakawa, Kento Ebihara, Takuma Kawada, Masayuki Fujino, Yuzuna Honda, Nami Ohashi, Tsutomu Murakami, Hirokazu Tamamura. DIMERIZED SMALL MOLECULE HIV-1 FUSION INHIBITORS WITH DRAMATIC ENHANCEMENT OF THEIR ANTI-HIV-1 ACTIVITIES. The 58th Japanese Peptide Symposium 2021.10.21 Online

  45. Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nami Ohashi, Wataru Nomura, Hirokazu Tamamura. A FRET-BASED ASSAY SYSTEM FOR PROTEIN KINASE C LIGAND SCREENING USING 1,2-DIACYLGLYCEROL-LACTONE DERIVATIVE. The 58th Japanese Peptide Symposium 2021.10.20 Online

  46. Hirokazu Tamamura. Development of Anti-HIV and Anti-cancer Peptides. The 18th Akabori Conference: Japanese-German Symposium on Peptide Science 2021.03.08 Online

  47. Kohei Tsuji. Kinase inhibitors for anti-cancer drugs. The 7th Joint Symposium between Chulalongkorn University and IBB/TMDU on Biomedical Materials and Engineering 2020.12.22 online (Thailand)

  48. Hirokazu Tamamura. Mid-size drugs based on peptidomimetics. The 7th Joint Symposium between Chulalongkorn University and IBB/TMDU on Biomedical Materials and Engineering 2020.12.22 online (Thailand)

  49. Hirokazu Tamamura. Bioimaging of GPCR dimers and its application to molecular probes for cancer cells. A3 Foresight & 5 Star Alliance Joint Workshop on Organic/Inorganic Hybrid Nano Materials and Bio Imaging 2020.12.03 online

  50. Kaho Matsumoto, Takeo Kuwata, Zahid Hasan, Yu Kaku, Shashwata Biswas, Shokichi Takahama, Hirokazu Tamamura and Shuzo Matsushita. The CD4 mimetic compound YIR-821-mediated enhancement of the neutralization activities of plasma IgG against autologous isolates in vitro.. 21st Kumamoto AIDS Seminar 2020.11.11 online(Kumamoto)

  51. Kofi Baffour-Awuah Owusu, Kohei Tsuji, Rongyi Wang, Takuya Kobayakawa, Moemi Kaneko, Tsutomu Murakami, Hirokazu Tamamura. Exploratory studies on the development of anti-HIV-1 peptides based on HIV-1 capsid fragments. The 57th Japanese Peptide Symposium 2020.11.10 online(Tottori)

  52. Kohei Tsuji, David Hyme, Buyong Ma, Ruth Nussinov, Hirokazu Tamamura,Terrence R. Burke, Jr.. Development of bivalent inhibitors of polo-like kinase 1 with great affinity enhancement. The 57th Japanese Peptide Symposium 2020.11.10 online (Tottori)

  53. Wataru Nomura, Takumi Kamimura, Takuya Kobayakawa, Hirokazu Tamamura. Endogenous protein expression imaging by fluorogenic ZIP tag-probe system. The 57th Japanese Peptide Symposium 2020.11.10 online (Tottori)

  54. Chika Azuma, Takuya Kobayakawa, Kohei Tsuji, Hirokazu Tamamura. A convergent synthesis of chloroalkene dipeptide isosteres as peptidomimetics. The 57th Japanese Peptide Symposium 2020.11.09 online (Tottori)

  55. Hirokazu Tamamura. Bivalent HIV-1 fusion inhibitors using peptidomimetics. 16th Chinese International Peptide Symposium 2020.09.25 online/Hefei, China (Keynote Speaker)

  56. Hirokazu Tamamura . Bivalent Ligands of GPCR as Molecular Measures, Bioprobes for Cancer Cells and Anti-cancer Agents. The 7th SNU Symposium on Medicinal Chemistry 2020.02.14 Seoul, Korea

  57. Hirokazu Tamamura . Peptide-lead medicinal chemistry: anti-cancer & HIV agents. The 6th Joint Symposium between Chulalongkorn University and IBB/TMDU on Biomedical Materials and Engineering 2020.01.14 Bangkok, Thailand

  58. 王容義、小早川拓也、金子萌美、Kofi Owusu、村上努、玉村啓和. カプシドタンパク質をもとにした細胞透過性抗HIV ペプチドの開発研究. 第37回メディシナルケミストリーシンポジウム 2019.11.28

  59. 村上努、海老原健人、小早川拓也、藤野真之、児玉栄一、玉村啓和. 二量体化HIV-1膜融合阻害剤の作用機構. 第33回日本エイズ学会学術集会・総会 2019.11.27 熊本

  60. 渡邉優基、小早川拓也、谷口敦彦、林良雄、玉村啓和. アミロイドβ凝集阻害活性を有する環状ペプチドへのCADI 導入の効果. 第37回メディシナルケミストリーシンポジウム 2019.11.27 東京

  61. 倉上真樹、小早川拓也、横山勝、村上努、金子萌美、小谷治、佐藤裕徳、玉村啓和. HIV-1 カプシドタンパク質の構造を基にした新規抗HIV-1 剤の構造活性相関研究. 第37回メディシナルケミストリーシンポジウム 2019.11.27 東京

  62. 東知佳、小早川拓也、玉村啓和. ペプチドミメティックを指向したクロロアルケン型ジペプチドイソスターの合成研究. 第37回メディシナルケミストリーシンポジウム 2019.11.27 東京

  63. 海老原健人、川田拓馬、小早川拓也、村上努、玉村啓和. HIV-1 膜融合を標的とする低分子化合物を基にした二価型膜融合阻害剤の創製. 第37回メディシナルケミストリーシンポジウム 2019.11.27 東京

  64. Elucidation of mechanism of HIV-1 fusion inhibitors developed by dimerization strategy. 第67回 日本ウイルス学会学術集会 2019.10.29 東京

  65. 松田幸樹、小早川拓也、土屋亮人、服部真一朗、潟永博之、吉村和久、岡慎一、遠藤泰之、玉村啓和、満屋裕明、前田賢次. HIV潜伏感染再活性化を介してリザーバー細胞にアポトーシスを誘導するPKC活性化剤の同定. 第67回 日本ウイルス学会学術集会 2019.10.29

  66. Wataru Nomura, Takumi Kamimura, Takuya Kobayakawa, Hirokazu Tamamura. Fluorogenic ZIP tag-probe system for fluorescent imaging of endogenous protein expression. 第56回ペプチド討論会 2019.10.25

  67. Rongyi Wang, Takuya Kobayakawa, Moemi Kaneko, Kofi Owusu, Tsutomu Murakami, Hirokazu Tamamura. Development of cell-permeable anti-HIV peptides based on capsid proteins. 第56回ペプチド討論会 2019.10.25

  68. Maxwell M. Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of a nanoBRET-based sensitive screening method to search for chemokine receptor CXCR4 ligands. 第56回ペプチド討論会 2019.10.25 東京

  69. Yuki Watanabe, Takuya Kobayakawa, Atsuhiko Taniguchi, Yoshio Hayashi, Hirokazu Tamamura. Development of peptidomimetic inhibitors for aggregation of amyloid beta. 2019.10.23 東京

  70. Kento Ebihara, Yuzuna Honda, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. Development of HIV-1 fusion inhibitors based on the C34 dimer derived from an HIV-1 envelope protein gp41. 第56回ペプチド討論会 2019.10.23 東京

  71. Masaki Kurakami, Takuya Kobayakawa, Masaru Yokoyama, Tsutomu Murakami, Moemi Kaneko, Osamu Kotani, Hironori Sato, Hirokazu Tamamura. Structure-activity relationship studies of small molecular anti-HIV-1 compounds targeting a dipeptide site of HIV-1 capsid proteins. 第56回ペプチド討論会 2019.10.23 東京

  72. Takuya Kobayakawa, Hirokazu Tamamura. Development of chemical synthesis for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. 第56回ペプチド討論会 2019.10.23 東京

  73. Hirokazu Tamamura. Elucidation of a dimerization state of a GPCR and its application to molecular probes for cancer cells. The 2019 International Conference on Molecular Imaging and Minimally Invasive Therapy (2019 MIMIT) 2019.10.18 Beijing, China

  74. Hirokazu Tamamura. Development of bivalent ligands of GPCR and their application to molecular probes for cancer cells and anti-cancer agents. 7th Modern Solid Phase Synthesis & Its Applications Symposium 2019.09.07 Palm Cove, Australia

  75. Tamamura H. Peptide drug discovery. 25th Peptide Forum – International Forum on Peptides in Drug Discovery - /Satellite Symposium of 10th International Peptide Symposium 2018.12.10 Tokyo, Japan

  76. Wataru Nomura , Takumi Kamimura, Daisuke Matsumoto, Takuya Kobayakawa, Hirokazu Tamamura. Fluorogenic and genetically encodable tag-probe system for in-cell imaging of protein synthesis . 10th International Peptide Symposium／55th Japanese Peptide Symposium 2018.12.05 Kyoto, Japan

  77. 小早川 拓也, 玉村 啓和. Synthetic Strategy of Peptidomimetic Based on Chloroalkene Dipeptide Isoteres and Its Biological Application. 10th International Peptide Symposium／55th Japanese Peptide Symposium 2018.12.03 Kyoto, Japan

  78. Tamamura H. Peptidomimetic-based mid-size drugs: anti-cancer and anti-HIV agents. 10th International Peptide Symposium／55th Japanese Peptide Symposium 2018.12.03 Kyoto, Japan

  79. Kento Ebihara, Yuzuna Honda, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. HIV-1 Fusion Inhibitors Based on gp41-C34 dimers. 10th International Peptide Symposium／55th Japanese Peptide Symposium 2018.12.03 Kyoto, Japan

  80. Takuya Kobayakawa, Kohei Takahashi, Ami Masuda, Shigeyoshi Harada, Tomoyuki Miura, Shuzo Matsushita, Kazuhisa Yoshimura, Hirokazu Tamamura. Structure‐activity relationship studies of CD4 mimic molecules for targeting an envelope protein gp120 on HIV-1. 19th Kumamoto AIDS Seminar 2018.11.06 Kumamoto, Japan

  81. Takuya Kobayakawa, Kohei Takahashi, Ami Masuda, Shigeyoshi Harada, Tomoyuki Miura, Shuzo Matsushita, Kazuhisa Yoshimura, Hirokazu Tamamura. Structure‐activity relationship studies of CD4 mimic molecules for targeting an envelope protein gp120 on HIV-1. 19th Kumamoto AIDS Seminar 2018.11.06 Kumamoto, Japan

  82. Tsutomu Murakami, Kento Ebihara, Masayuki Fujino, Yuzuna Honda, Takuya Kobayakawa, Wataru Nomura, Hirokazu Tamamura. Development of new membrane fusion inhibitors against HIV-1 by “dimerization” strategy. 第66回日本ウイルス学会学術集会 2018.10.28 京都

  83. Maxwell M. Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of a new NanoBRET assay system for CXCR4 ligands and their Structure-activity relationship studies. Frontiers 2018 Symposium (EPFL/TMDU/UTokyo Joint Symposium) 2018.09.21 Lausanne, Switzerland

  84. Tamamura H. Peptidomimetic-based mid-size drugs: anti-cancer and anti-HIV agents. Frontiers 2018 Symposium (EPFL/TMDU/UTokyo Joint Symposium) 2018.09.21 Lausanne,Switzerland

  85. Daisuke Matsumoto, Wataru Nomura, Hirokazu Tamamura. Split site-specific nucleases for controlled genome editing by chemicals. Frontiers 2018 Symposium (EPFL/TMDU/UTokyo Joint Symposium) 2018.09.21 Lausanne, Switzerland

  86. サキヤマ・マクスウェル, 野村 渉, 小早川 拓也, 玉村 啓和. Development of NanoBRET assay system in living cells for structure-activity relationship studies of CXCR4 ligands. 第62回 日本薬学会 関東支部大会 2018.09.15 東京

  87. Tamamura H. Synthesis of Peptidomimetics Based on Chloroalkene Dipeptide Isosteres and Their Biological Application. The 17th Akabori Conference 2018: German- Japanese Symposium on Peptide Science 2018.09.04 Lindau,Germany

  88. Tamamura H. HIV-1 fusion inhibitors based on the C34 dimers derived from gp41. 15th Chinese International Peptide Symposium 2018.07.04 Shenzhen,China

  89. Maxwell M. Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of NanoBRET assay system in living cells to search potent CXCR4 ligands. 日本ケミカルバイオロジー学会第13回年会 2018.06.13 東京

  90. Tsutomu Murakami, Masayuki Fujino, Masaru Yokoyama, Takuya Kobayakawa, Hiroaki Takeuchi, Takao Masuda, Osamu Kotani, Hirokazu Tamamura, Hironori Sato. Biological and molecular characterization of a novel anti-HIV-1 compound created by in silico design and de novo organic synthesis. Cold Spring Harbor Laboratory Meetings & Courses, Retrovirus Meeting 2018.05.23 Cold Spring Harbor, United States of America

  91. サキヤマ マクスウエル, 野村 渉, 玉村 啓和. CXCR4 リガンド候補化合物の探索を指向した高感 度スクリーニング手法の開発. 日本薬学会第138年会 2018.03.26 石川

  92. Nomura W, Matsumoto D, Sugii T, Kobayakawa T, Tamamura H. Differential regulation of endogenous genes in an orthogonal manner by distinct chemically inducible systems. International Conference on Epigenetics and Bioengineering 2017.12.13 Miami, USA

  93. Tamamura H. Synthesis of chloroalkene dipeptide isosteres as peptidomimetics and their biological application. 12th Australian Peptide Conference 2017 2017.10.17 Noosa, Australia

  94. Toyama K, Nomura W, Tamamura T. Functional evaluation of intracellular delivery peptides based on the EGF receptor dimerization arm sequences. 12th Australian Peptide Conference 2017 2017.10.16 Noosa, Australia

  95. Nomura W, Matsumoto D, Hashimoto T, Sugii T, Tamamura H. Development of chemical-inducible artificial transcription factors based on sequence-specific DNA binders. the 254th ACS National Meeting and Exposition 2017.08.20 Washington DC, USA

  96. Ohashi N, Harada S, Irahara Y, Ishida Y, Konno K, Kobayakawa T, Nomura W, Matsushita S, Yoshimura K, Tamamura H. CD4 Mimics for Enhancement of Activity of HIV Neutralizing Antibodies. The 11th AFMC International Medicinal Chemistry Symposium 2017.07.24 Melbourne, Australia

  97. Tamamura H. Rigid bivalent ligands of the chemokine receptor CXCR4 and their anti-cancer metastasis activity. KCS Biochemistry Division Summer Workshop 2017.06.27 Jeju, Korea

  98. Ebihara K, Honda Y, Nomura W, Murakami T, Tamamura H. Development of HIV-1 fusion inhibitors based on the C34 dimers derived from gp41. The 21st Korean Peptide Protein Society Symposium 2017.06.25 Jeju, Korea

  99. Nomura W, Tanaka T, Aoki T, Tamamura H. Bivalent Ligands of the Chemokine Receptor CXCR4 with Polyproline Linkers and Their Anti-chemotactic Activity. The 25th American Peptide Symposium and the 9th International Peptide Symposium 2017.06.21 Whistler, Canada

  100. Kobayakawa T, Tamamura H. Development of Synthetic Methods for Chloroalkene Dipeptide Isosteres and Their Applications. The 25th American Peptide Symposium and the 9th International Peptide Symposium 2017.06.19 Whistler, Canada

  101. Nomura W, Sugii T, Tamamura H. Chemical-inducible artificial transcription factors based on sequence-specificity of TALE and dCas9. Keystone Symposia Precision Genome Engineering 2017.01.08 Breckenridge, USA

  102. HashimotoT, Nomura W, Ohura I, Tamamura H. Improved split DNA methylase activity by optimization of assembly on target sites. Keystone Symposia Precision Genome Engineering 2017.01.08 Breckenridge, USA

  103. Matsumoto D, Nomura W, Tamamura H. Controllable genome editing by chemically inducible split site-specific nucleases. Keystone Symposia Precision Genome Engineering 2017.01.08 Breckenridge, USA

  104. Tamamura H. Medicinal Chemistry/Peptide & Protein Chemistry/Chemical Biology- Peptidomimetic-based Mid-Size Drugs –. The 3rd Joint Symposium between Chulalongkorn University and IBB/TMDU on Biomedical Materials and Engineering, Chulalongkorn University 2016.12.15 Bangkok, Thailand

  105. Nomura W, Tamamura H. Design of synthetic peptides mimicking dynamic supramolecular mechanisms in HIV fusion as antigens and inhibitors against trimer-form of gp41. Antibody Engineering & Therapeutics 2016.12.12 San Diego, California

  106. Tamamura H. Mid-size Drugs: Peptide-lead Anti-HIV Agents. The 2nd Peptides and Proteins Symposium Singapore 2016.12.09 Singapore, Singapore

  107. Kobayakawa T, Matsuzaki Y, Nomura W, Hozumi K, Nomizu M and Tamamura H. Development of Chloroalkene Dipeptide Isosteres as Peptidomimetics and Their Application. 2016.12.08 Singapore, Singapore

  108. Tamamura H. Mid-sized drugs based on peptide mimetics. 15th Surugadai International Symposium 2016.11.29 Tokyo, Japan

  109. Takano H, Nomura W, Tamamura H. Development of a Hydrophilic Caged PKC Ligand with an 8-Azacoumarin Photolabile Protecting Group for the Precise Photocontrol of PKC Activation. 34th European Peptide Symposium 2016 & 8th International Peptide Symposium 2016.09.08 Leipzig, Germany

  110. Toyama K, Mizuguchi T, Nomura W, Tamamura H. Functional Evaluation of Fluorescein-Labeled Peptides Based on the EGF Receptor Dimerization Arm Sequences. 34th European Peptide Symposium 2016 & 8th International Peptide Symposium 2016.09.08 Leipzig, Germany

  111. Tamamura H. Mid-Size Drugs: Dimer& Trimer Mimics of HIV-gp41 Peptides as Fusion Inhibitors. 34th European Peptide Symposium 2016 & 8th International Peptide Symposium 2016.09.05 Leipzig, Germany

  112. Kobayakawa T, Tamamura H. Development of synthetic methodology of chloroalkene-type dipeptide isosteres for peptidomimetics. 252nd American Chemical Society National Meeting 2016.08.23 Philadelphia, USA

  113. Nomura W, Ohashi N, Tamamura H. Protein Dynamics Imaging Using Tag-probe Systems. The 14th Chinese International Peptide Symposium & the 5th Asia-Pacific International Peptide Symposium 2016.07.06 Nanjing, China

  114. Miyaki D, Mizuguchi T, Nomura T, Takahashi D, Tamamura H. Synthesis of Anti-Integrase Stapled Peptides with a Soluble Linker. The 14th Chinese International Peptide Symposium & the 5th Asia-Pacific International Peptide Symposium 2016.07.06 Nanjing, China

  115. Tamamura H. Mid-Size Drugs: HIV Fusion Inhibitors Based on the C34 Dimer/Trimer Derived from gp41. The 20th Korean Peptide Protein Society Symposium 2016.06.24 Yangyang, Korea

  116. Toyama K, Mizuguchi T, Nomura W, and Tamamura H. Development of New Fluorescein-Labeled Peptides with Inhibitory Effect on the EGF Receptor Activation. The 20th Korean Peptide Protein Society Symposium 2016.06.24 Yangyang, Korea

  117. Nomura W, Sugii T, Tamamura H. Chemically-inducible gene regulation system utilizing sequence-specificity of TALE and dCas9. FASEB SRC: Genome Engineering: Cutting-Edge Research and Applications 2016.06.08 Lisbon、Portugal

  118. Nomura W, Ohashi N, Tamamura H. Tag-probe Systems for Protein Dynamics Imaging. The 16th Akabori Conference: Japanese-German Symposium on Peptide Science 2016.05.24 Kobe, Japan

  119. Nomura W, Ohashi N, Tamamura H. In-cell fluorogenic tag-probe system for protein localization and dynamics imaging. 251st American Chemical Society National Meeting 2016.03.17 San Diego, USA

  120. Takano H, Narumi T, Nomura W, Furuta T, Tamamura H. Development of water-soluble and highly photosensitive 8-azacoumarin-4-ylmethyl-type photolabile-protecting groups for dynamic analysis of bioactive molecules. 251st American Chemical Society National Meeting 2016.03.16 San Diego, USA

  121. Nomura W, Masuda A, Tamamura H. Efficient conversion of genomic promoter region by genome engineering systems. Pacifichem 2015 2015.12.15 Honolulu, USA

  122. Tamamura H. Multivalent ligands for CXCR4 with polyproline linkers showing specific recognition for its expression. The 7th International Peptide Symposium 2015.12.11 Singapore, Singapore

  123. Tamamura H. Multivalent ligands showing specific recognition for CXCR4 expression. The Seventh Peptide Engineering Meeting (PEM7) 2015.12.07 Pune, India

  124. 谷田部夏香, 松本大地, 橋本知恵, 藤野真之, 水口貴章, 大橋南美, 野村　渉, 村上　努, 玉村啓和. HIV-1カプシドタンパク質由来ペプチドライブラリーの構築と阻害剤の創出. 第29回日本エイズ学会学術集会・総会 2015.11.30

  125. 水口貴章, 苛原　優, 原田恵嘉, 三浦智行, 小谷みさと, 石田有佑, 山田裕子, 大橋南美, 野村　渉, 松下修三, 吉村和久, 玉村啓和. 薬物動態の改善を志向した低分子CD4ミミックの創製研究. 第29回日本エイズ学会学術集会・総会 2015.11.30 東京

  126. Misato Kotani, Yu Irahara, Yusuke Ishida, Shigeyoshi Harada, Nami Ohashi, Yuko Yamada, Takaaki Mizuguchi, Tomoyuki Miura, Wataru Nomura, Shuzo Matsushita, Kazuhisa Yoshimura, Hirokazu Tamamura. Development of small CD4 mimic molecules with a mono-cyclohexyl type group targeting HIV-1 gp120. 第29回日本エイズ学会学術集会・総会 2015.11.30 東京

  127. 石田有佑, 水口貴章, 原田恵嘉, 三浦智行, 小谷みさと, 山田裕子, 苛原　優, 　野村　渉, 松下修三, 吉村和久, 玉村啓和. 新規CD4ミミックの創製と薬物動態解析. 第29回日本エイズ学会学術集会・総会 2015.11.30 東京

  128. 宮木大輔, 水口貴章, 村上　努, 野村　渉, 玉村啓和. HIV-1遺伝子産物ペプチドを基とするインテグラーゼ阻害剤の構造活性相関研究. 第29回日本エイズ学会学術集会・総会 2015.11.30 東京

  129. 本田柚子奈, 野村　渉, 藤野真之, 村上　努, 玉村啓和. HIV外被タンパク質gp41の断片ペプチドC34を基にした二量化膜融合阻害剤の創製. 第29回日本エイズ学会学術集会・総会 2015.11.30 東京

  130. 小早川拓也, 玉村啓和. ペプチド結合の基底状態模倣体を指向したクロロアルケン型ジペプチドイソスターの創製研究. 第33回メディシナルケミストリーシンポジウム 2015.11.26 幕張

  131. 石田有佑, 水口貴章, 原田恵嘉, 三浦智行, 小谷みさと, 山田裕子, 苛原　優, 野村　渉, 松下修三, 吉村和久, 玉村啓和. カテコール誘導体を基盤とした新規CD4ミミックの創製と薬物動態解析. 第33回メディシナルケミストリーシンポジウム 2015.11.26 幕張

  132. 水口貴章, 外山　桂, 石田有佑, 野村　渉, 玉村啓和. 上皮成長因子受容体の「二量体化アーム」を基盤とした新規抗がん薬開発に向けた環状ペプチドに関する研究. 第33回メディシナルケミストリーシンポジウム 2015.11.26 幕張

  133. Yuzuna Honda, Masayuki Fujino, Wataru Nomura, Hirokazu Tamamura, Tsutomu Murakami. Dimerization of C34 Derivatives with C-Terminal Disulfide Bridge and Addition of an N-Terminal GCGG Markedly Enhance anti-HIV-1 Activity. 第63回日本ウイルス学会学術集会 2015.11.22 福岡

  134. Nomura W, Masuda A, Tamamura H. Simultaneous digestion by site-specific nucleases for efficient gene deletion: Study of hTERT promoter function. Conference on Transposition and Genome Engineering 2015 2015.11.17 Nara. Japan

  135. Takaaki Mizuguchi, Kei Toyama, Yusuke Ishida, Wataru Nomura, Hirokazu Tamamura. Functional Evaluation of Fluorescent-Labeled Derivatives of an Inhibitory Peptide against EGF Receptor Dimerization. 第52回ペプチド討論会 2015.11.16

  136. Takayoshi Higashi, Nami Ohashi, Wataru Nomura, Hirokazu Tamamura. Development of a Highly Sensitive Assay Method for Ligand Binding with a Fluorescent Labeled PKC δC1b Domain. 第52回ペプチド討論会 2015.11.16 平塚

  137. Takuya Kobayakawa, Tetsuo Narumi, Hirokazu Tamamura. Stereoselective Synthesis of Chloroalkene Dipeptide Isosteres Utilizing Organocopper Reagents. 第52回ペプチド討論会 2015.11.16 平塚

  138. Hikaru Takano, Tetsuo Narumi, Wataru Nomura, Toshiaki Furuta, Hirokazu Tamamura. Improvement of Photolytic Efficiency of the 8-Azacoumarin Chromophore Induced by Iodine Functionalization. 第52回ペプチド討論会 2015.11.16 平塚

  139. Kei Toyama, Takaaki Mizuguchi, Yusuke Ishida, Wataru Nomura, Hirokazu Tamamura. Studies on a Novel Delivery Peptide Derived from the Dimerization Arm of EGF Receptor. 第52回ペプチド討論会 2015.11.16 平塚

  140. Nami Ohashi, Wataru Nomura, Natsuki Minato, Hirokazu Tamamura. FRET-Based Binding Assay for PKC Ligands with Small Fluorescent Dyes. 第52回ペプチド討論会 2015.11.16

  141. Yuzuna Honda, Wataru Nomura, Masayuki Fujino, Tsutomu Murakami, Hirokazu Tamamura. Development of Dimeric Inhibitors Derived from a gp41 Fragment against HIV-1 Membrane Fusion Utilizing an Intermolecular Disulfide Bridge. 第52回ペプチド討論会 2015.11.16 平塚

  142. Wataru Nomura, Akemi Masuda, Hirokazu Tamamura. Genome Deletion by ZFN and CRISPR-Cas Targeting Promoter Region for Analysis of hTERT Function. 「細胞を創る」研究会8.0 2015.11.12 吹田

  143. Nomura W, Honda Y, Mizuguchi T, Tamamura H. Peptidomimetic-based Mid-size Drug Research: Anti-HIV Agents. The 10th AFMC International Medicinal Chemistry Symposium 2015.10.19 Jeju, Korea

  144. Mizuguchi T, Ohashi N, Nomura W, Murakami T, Tamamura H. An anti-HIV assay method for cell-penetrating peptides using chloroquine and identification of inhibitory peptides derived from matrix proteins. The 16th Kumamoto AIDS Seminar 2015.10.08 Kumamoto, Japan

  145. Kotani M, Irahara Y, Ishida Y, Harada S, Ohashi N, Yamada Y, Mizuguchi T, Miura T, Nomura W, Matsushita S, Yoshimura K, Tamamura H. New design of small CD4 mimic molecules targeting HIV-1 gp120. 2015.10.07 Kumamoto, Japan

  146. Honda Y, Nomura W, Fujino M, Murakami T, Tamamura H. Development of dimeric inhibitors against HIV-1 fusion utilizing disulfide bonds derived from gp41 fragment peptides. The 16th Kumamoto AIDS Seminar 2015.10.07 Kumamoto, Japan

  147. Tamamura H. Development of peptide-lead anti-HIV agents and chemical biology. Department of Pharmacology and Experimental Neuroscience – Seminar Series in University of Nebraska Medical Center 2015.10.02 Omaha, USA

  148. Ohashi N, Nomura W, Minato N, Tamamura H. Development of a FRET Based PKC Ligand Screening Method. The 19th Korean Peptide Protein Symposium 2015.07.06 Taean, Korea

  149. Honda Y, Nomura W, Fujino M, Murakami T, Tamamura H. Dimerization of C34 Derivatives with C-Terminal Disulfide Bridge and the Addition of an N-Terminal GCGG Sequence Extremely Increase HIV-1 Inhibitory Activity. The 19th Korean Peptide Protein Symposium 2015.07.06 Taean, Korea

  150. Tamamura H. Development of anti-HIV agents and prevention of HIV infection. Taipei Medical University-Tokyo Medical and Dental University Joint Symposium 2015: Preventive Medicine and Dentistry 2015.05.14 Tokyo, Japan

  151. Nomura W, Masuda A, Tamamura H.. Enhanced Gene Disruption by Simultaneous Digestion of ZFN or CRISPR/Cas System at hTERT Promoter Region. FASEB SRC "Genome Engineering Cutting-Edge Research and Applications” . FASEB SRC "Genome Engineering Cutting-Edge Research and Applications" 2014

  152. Mizuguchi T, Yamazaki Y, Kobayashi K, Ooe H, Iida M, Ninomiya R, Saito K, Akaji K, Tamamura H.. Studies on Identification of Active Sites of an Inhibitory Cyclic Peptide against EGF Receptor Dimerization.. The 51th Japanese Peptide Symposium 2014

  153. Takano H, Narumi T, Nomura W, Furuta T, Tamamura H. Development of 8-Azacoumarin-4-ylmethyl-type Photolabile Protecting Groups Based on Amide-alkene Isosterism.. The 51th Japanese Peptide Symposium 2014

  154. Kobayakawa T, Narumi T, Tamamura H. Development of Efficient Synthetic Methodologies of Chloroalkene Dipeptide Isosteres. The 51th Japanese Peptide Symposium 2014

  155. Honda Y, Mizuguchi T, Nomura W, Tamamura H. Development of Dimeric Peptide Derivatives Based on gp41 Fragments as HIV-1 Fusion Inhibitors. The 51th Japanese Peptide Symposium 2014

  156. Nomura W, Koseki T, Mizuguchi T, Tamamura H. Design and Synthesis of Trivalent CXCR4 Ligands Utilizing Polyproline Linkers. The 51th Japanese Peptide Symposium 2014

  157. Kotani M, Hirota Y, Irahara Y, Harada S, Yamada Y, Ohashi N, Mizuguchi T, Nomura W, Matsushita S, Yoshimura K, Tamamura H.. Structure-activity Relationship Studies of CD4 Mimic Molecules.. The 15h Kumamoto AIDS Seminar. 2014

  158. Irahara Y, Kotani M, Harada S, Narumi T, Yamada Y, Hirota Y, Ohashi N, Mizuguchi T, Nomura W, Matsushita S, Yoshimura K, Tamamura H.. A New Type of Small CD4 Mimic Molecules Targeting an HIV Envelope Protein gp120.. The 15h Kumamoto AIDS Seminar. 2014

  159. Yamada Y, Hashimoto C, Otsuki H, Hirota Y, Yoshimura K, Harada S, Ohashi N, Mizuguchi T, Nomura W, Miura T, Igarashi T, Matsushita S, Tamamura H.. A CD4 Mimic as an HIV Entry Inhibitor: Pharmacokinetics... The 15h Kumamoto AIDS Seminar. 2014

  160. Nomura W, Métifiot M, Ohashi N, Fujino M, Mizuguchi T, Yamamoto N, Pommier Y, Komano JA, Murakami T, Tamamura H.. Cell-permeable Stapled Peptides with Integrase Inhibitory Activity Derived from HIV Gene Products.. The 15h Kumamoto AIDS Seminar. 2014

  161. Nomura W, Hashimoto C, Fujino M, Murakami T, Ohashi N, Tamamura H.. Multimerized Peptides Derived from the C-Terminal Region of HIV-1 gp41 as Fusion Inhibitors.. The 33rd European Peptide Society Symposium. 2014

  162. Nomura W, Masuda A, Tamamura H.. Efficient Gene Disruption at hTERT Promoter Region by Simultaneous Digestion by Pairs of ZFNs or Guide RNAs of CRISPR/Cas System.. The 28th annual symposium of protein society. 2014

  163. Nomura W, Masuda A, Tamamura H.. Enhanced Gene Disruption at Specific Promoter Region by Simultaneous Digestion of ZFN or CRISPR/Cas System.. The Synthetic Biology: Engineering, Evolution & Design (SEED) conference 2014

  164. Development of Bivalent Ligands for CXCR4 with Rigid Linkers and Application to Detection of Cancer Cells. 22nd American Peptide Symposium 2011

  165. Design and Synthesis of Traceable Linker for Efficient Enrichment and Specific Labeling of Target Proteins. 22nd American Peptide Symposium 2011

  166. Studies for Optimum Design of Artificial Zinc Finger Recombinases by Evaluation of Effects of DNA Binding Affinity and Linker Components on Recombination Efficiency. 22nd American Peptide Symposium 2011

  167. Synthesis of HIV Gp41 Trimer Mimics Inducing Neutralizing Antibodies Based on Remodeling of Dynamic Structures of HIV-1 Envelope Proteins. 22nd American Peptide Symposium 2011

  168. Identification of Anti-HIV Peptides Derived from Matrix Proteins. ACS Meeting Fall2011 2011

  169. Synthesis of C1b Domains of Protein Kinase C Having Solvatochromism and their Application to Bio-sensing. The 9th Australian Peptide Conference 2011

  170. Sequence-Specific Recombination Enabled by a Pair of Zinc Finger Recombinases. The 9th Australian Peptide Conference 2011

  171. Synthetic Studies on (Z) and (E)-Chloroalkene Skeltons As Amide Bond Equivalents. 8th AFMC International Medicinal Chemistry Symposium 2011

  172. SAR Studies of Small Molecular CD4 Mimics Targeting the HIV Entry Mechanism. 8th AFMC International Medicinal Chemistry Symposium 2011

  173. N-(Benzoyloxy)sulfonamides-Mediated Aziridination of α, β-Unsaturated Enones. 8th AFMC International Medicinal Chemistry Symposium 2011

  174. Development of Artificial Recombinases for Genome Editing. 8th AFMC International Medicinal Chemistry Symposium 2011

  175. Synthetic Antigens for Induction of Structure-Specific Antibodies against Trimer-Form of gp41. 8th AFMC International Medicinal Chemistry Symposiu 2011

  176. CXCR4-Derived Peptides Targeting AIDS Vaccines. 8th AFMC International Medicinal Chemistry Symposium 2011

  177. Several HIV Inhibitors Targeting Entry, Fusion, Integrase and Matrix. 8th AFMC International Medicinal Chemistry Symposium 2011

  178. Development of Photochemically Removable Protecting Groups in Hydrophilic Environments: Synthesis and Photochemical Property of 8-Azacoumarins. 8th AFMC International Medicinal Chemistry Symposium 2011

  179. Application of Stimulus-responsive Amino Acid to Traceable Linker for Efficient Enrichment and Specific Labeling of Target Proteins. 8th AFMC International Medicinal Chemistry Symposium 2011

  180. Development of Small CD4 Mimic Molecules that Induce Conformational Changes in gp120. 11th KUMAMOTO AIDS Seminer-GCOE Joint International Symposium 2010

  181. Kinetic Analysis of Split DNA Methylase in DNA Recognition and Methylation. 2010 International Chemical Congress of Pacific Basin Societies 2010

  182. Peptidic HIV Integrase Inhibitors Derived from HIV Gene Products. Tamamura H.. 11th KUMAMOTO AIDS Seminer -GCOE Joint International Symposium 2010

  183. Synthesis and Evaluation of CXCR4-derived Peptides Targeting the Development of AIDS Vaccines. 5th International Peptide Symposium 2010

  184. Structure-Activity Relationships of CXCR4 Antagonists Having the Dipicolylamine/Azamacro- Cyclic-Metal Complex Structures.. 11th KUMAMOTO AIDS Seminer-GCOE Joint International Symposium 2010

  185. Strategy to Overcome Neutralization Resistance of HIV-1 Primary Isolates. 11th KUMAMOTO AIDS Seminer-GCOE Joint International Symposium 2010

  186. Peptidic HIV Integrase Inhibitors Derived from HIV Gene Products. 11th KUMAMOTO AIDS Seminer -GCOE Joint International Symposium 2010

  187. Effects of DNA binding and linker length on recombination of artificial zinc-finger recombinase. The 37th International Symposium on Nucleic Acids Chemistry 2010 2010

  188. Anti-HIV Inhibitors and AIDS Vaccines.. International Summer Program 2010 2010

  189. Elucidation of a Dimerization State of a Chemokine Receptor CXCR4 via Chemical Biology Approach Utilizing Novel Bivalent Ligands with Rigid Polyproline Linkers. The 13th Akabori Conference Leipzig 2010: Japanese-German Symposium on Peptide Science 2010

  190. Novel Tag-probe Pairs for Fluorescent Imaging of Proteins in Living Cells. 5th International Peptide Symposium 2010

  191. Development of a Bivalent Ligand for a Chemokine Receptor CXCR4 by Utilizing Polyproline Helix as a Linker. 5th International Peptide Symposium 2010

  192. α,α-Dicholoroisoxazolidinones for The Synthesis and Chemoselective Peptide Ligation of α-Peptide α-Ketoacids. 5th International Peptide Symposium 2010

< PREV - NEXT >

  • 1
To the head of this page.▲